> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# AdvaMed Prioritizes CDRH Proposed Guidances
- URL: https://www.fdaweb.com/advamed-prioritizes-cdrh-proposed-guidances/
- Published: 2016-03-02T12:00:00.000Z
- Updated: 2026-09-15T02:40:05.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5134948

> AdvaMed has submitted its suggested [priorities](http://www.regulations.gov/contentStreamer?documentId=FDA-2012-N-1021-0026&attachmentNumber=1&disposition=attachment&contentType=pdf&ref=fdaweb.com) for CDRH’s FY 2016 proposed guidance development. The trade group also submitted recommendations for guidance documents it believes should be part of the Center’s 2016 plans, but are not, along with recommendations on guidances to be updated or withdrawn.  
>  
> For proposed guidances listed in the Center’s “A” and “B” lists, AdvaMed assigned a high, medium, or low priority as determined by its member companies. It said that high priority guidances are those that have the potential to broadly affect industry, have high impact on routine administrative and/or review procedures at FDA, address an area where guidance may currently be lacking, or is required under the MDUFA 3 commitment letter or FDASIA legislation.  
>  
> Medium priority documents also may broadly affect industry, but may not be absolutely critical to FDA’s routine administrative and/or review procedures. Finally, low priority documents as determined by AdvaMed have a lesser impact on agency procedures or address a subject that is highly specialized or narrowly focused.